Atorvastatin (Lipitor) Therapy in Patients With Clinically Isolated Syndrome (CIS) at Risk for Multiple Sclerosis

NCT00094172 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

82

Enrollment

NIH

Sponsor class

Conditions

Multiple Sclerosis

Interventions

DRUG: Atorvastatin
DRUG: Placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]